These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2360470)

  • 1. Effects of HA1077, a novel calciumantagonistic spasmolytic agent on intracerebral arterioles of rats.
    Takayasu M; Dacey RG
    Acta Neurochir (Wien); 1990; 103(1-2):67-70. PubMed ID: 2360470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of action of a novel antivasospasm drug, HA1077.
    Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Takayasu M; Hidaka H
    J Pharmacol Exp Ther; 1987 Jun; 241(3):1033-40. PubMed ID: 3598899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of calcium antagonists on intracerebral penetrating arterioles in rats.
    Takayasu M; Bassett JE; Dacey RG
    J Neurosurg; 1988 Jul; 69(1):104-9. PubMed ID: 3379464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of intracellular actions of calcium may protect against ischaemic damage to the gerbil brain.
    Asano T; Ikegaki I; Satoh S; Mochizuki D; Hidaka H; Suzuki Y; Shibuya M; Sugita K
    Br J Pharmacol; 1991 Aug; 103(4):1935-8. PubMed ID: 1912980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of mannitol on intracerebral arteriolar diameter in vitro: extraluminal and intraluminal application.
    Takayasu N; Dacey RG
    Neurosurgery; 1989 Nov; 25(5):747-51; discussion 751-2. PubMed ID: 2511500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of HA1077, an intracellular calcium antagonist, on neurotransmitter metabolism in rat brain in vivo.
    Kondoh Y; Mizusawa S; Murakami M; Nagata K; Nakamichi H; Watanabe K
    Metab Brain Dis; 1991 Sep; 6(3):111-24. PubMed ID: 1779923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase.
    Asano T; Suzuki T; Tsuchiya M; Satoh S; Ikegaki I; Shibuya M; Suzuki Y; Hidaka H
    Br J Pharmacol; 1989 Dec; 98(4):1091-100. PubMed ID: 2611484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of isoquinoline derivatives, HA1077 and H-7, on cytosolic Ca2+ level and contraction in vascular smooth muscle.
    Takizawa S; Hori M; Ozaki H; Karaki H
    Eur J Pharmacol; 1993 Dec; 250(3):431-7. PubMed ID: 8112403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HA1077, a novel calcium antagonistic antivasospasm drug, increases both cerebral blood flow and glucose metabolism in conscious rats.
    Sako K; Tsuchiya M; Yonemasu Y; Asano T
    Eur J Pharmacol; 1991 Dec; 209(1-2):39-43. PubMed ID: 1814759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin: a potential modulator of cerebral vasospasm.
    Asano T; Ikegaki I; Satoh S; Suzuki Y; Shibuya M; Sugita K; Hidaka H
    Eur J Pharmacol; 1990 Nov; 190(3):365-72. PubMed ID: 2272374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Possible prophylactic potential of HA1077, a Ca2+ channel antagonist and vasodilator, on chronic cerebral vasospasm.
    Satoh S; Suzuki Y; Harada T; Ikegaki I; Asano T; Shibuya M; Sugita K; Hidaka H
    Eur J Pharmacol; 1992 Sep; 220(2-3):243-8. PubMed ID: 1425995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new type of vasodilator, HA1077, an isoquinoline derivative, inhibits proliferation of bovine vascular smooth muscle cells in culture.
    Shirotani M; Yui Y; Hattori R; Kawai C
    J Pharmacol Exp Ther; 1991 Nov; 259(2):738-44. PubMed ID: 1941621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of myosin light chain phosphorylation in cultured smooth muscle cells by HA1077, a new type of vasodilator.
    Sasaki Y; Sasaki Y
    Biochem Biophys Res Commun; 1990 Sep; 171(3):1182-7. PubMed ID: 2222437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs.
    Takayasu M; Suzuki Y; Shibuya M; Asano T; Kanamori M; Okada T; Kageyama N; Hidaka H
    J Neurosurg; 1986 Jul; 65(1):80-5. PubMed ID: 3712031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of HA1077, a protein kinase inhibitor, on myosin phosphorylation and tension in smooth muscle.
    Seto M; Sasaki Y; Hidaka H; Sasaki Y
    Eur J Pharmacol; 1991 Mar; 195(2):267-72. PubMed ID: 1874276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective inhibition of myosin phosphorylation and tension of hyperplastic arteries by the kinase inhibitor HA1077.
    Seto M; Shindo K; Ito K; Sasaki Y
    Eur J Pharmacol; 1995 Mar; 276(1-2):27-33. PubMed ID: 7781692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of an intracellular calcium antagonist HA 1077 on delayed cerebral vasospasm in dogs.
    Shibuya M; Suzuki Y; Takayasu M; Asano T; Harada T; Ikegaki I; Satoh S; Hidaka H
    Acta Neurochir (Wien); 1988; 90(1-2):53-9. PubMed ID: 3344625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compared effects of calcium entry blockers on calcium-induced tension in rat isolated cerebral and peripheral resistance vessels.
    Julou-Schaeffer G; Freslon JL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):670-6. PubMed ID: 3444482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of specific receptors and calcium mechanisms in serotonergic contractile response of isolated cerebral and peripheral arteries from rats.
    Chang JY; Owman C
    J Pharmacol Exp Ther; 1987 Aug; 242(2):629-36. PubMed ID: 3612555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.